|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 19 March 2009
doi: 10.1242/jcs.034736
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |

1 State Key Laboratory of Molecular Biology, Chinese Academy of Sciences, 200031 Shanghai, China
2 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 200031 Shanghai, China
3 Laboratory of Molecular Cell Biology, Key Laboratory of Stem Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 200031 Shanghai, China
Author for correspondence (e-mail: hgxgene{at}sunm.shcnc.ac.cn)
Accepted 2 December 2008
| Summary |
|---|
|
|
|---|
Key words: NDST1, BMP signaling, Lung development
| Introduction |
|---|
|
|
|---|
A number of signaling pathways including BMP, FGF, hedgehog and Wnt depend on heparan sulfate proteoglycans (HSPGs) (Hacker et al., 2005
; Lin, 2004
). HSPGs are macromolecules composed of heparan sulfate glycosaminoglycan (GAG) side chains covalently bound to core proteins. Biosynthesis of heparan sulfate (HS) is initiated from a chain composed of repeated D-glucuronic acid (GlcUA) N-acetyl-D-glucosamine (GlcNAc) residues. The glucosaminoglycan chains first undergo N-deacetylation and N-sulfation of selected GlcNAc residues by GlcNAc N-deacetylase/N-sulfotransferase (NDST) (Lindahl et al., 1998
; Salmivirta et al., 1996
). The subsequent modifications, such as C-5 epimerization of GlcA to iduronic acid (IdoA) and O-sulfation at various positions, are dependent on the prior N-sulfation of GlcN units created by NDST (Esko and Selleck, 2002
; Lindahl et al., 1998
). NDST has a key role in the modification of the HS polysaccharide chain.
Genes encoding four known NDST isozymes, Ndst1-Ndst4, have been identified in mammals (Aikawa and Esko, 1999
; Aikawa et al., 2001
; Eriksson et al., 1994
; Hashimoto et al., 1992
; Kusche-Gullberg et al., 1998
). Ndst1 and Ndst2 are expressed ubiquitously in both embryonic and adult mice, whereas Ndst3 and Ndst4 are mostly expressed during embryonic development (Ford-Perriss et al., 2002
; Grobe et al., 2002
; Miettinen et al., 1997
; Yabe et al., 2005
). Mice lacking Ndst2 have abnormal mast cells without properly sulphated heparin and mast-cell proteases (Forsberg et al., 1999
; Humphries et al., 1999
), and those lacking Ndst3 have no obvious phenotype (Grobe et al., 2002
). However, disruption of Ndst1 results in severe malformations in lung, brain, cranial facial, lens, vascular, skeletal, and lacrimal gland development (Abramsson et al., 2007
; Fan et al., 2000
; Grobe et al., 2005
; Hu et al., 2007
; Pan et al., 2008
; Pan et al., 2006
; Ringvall et al., 2000
). Thus, NDST1 is an essential NDST isozyme in mouse embryonic development.
Previously we reported that Ndst1 mutant mice developed atelectasis and respiratory distress and died shortly after birth (Fan et al., 2000
). However, the detailed developmental defects and the underlying mechanisms of NDST1-depedent HS modulation of signaling pathways remain unclear. Here, we report that BMP signaling is affected in Ndst1 mutant lung, which could be one of the causes of defective lung development.
| Results |
|---|
|
|
|---|
|
Defective differentiation of lung cells in Ndst1 mutants
Neonatal respiratory distress observed in Ndst1 mutants might be caused by reduced production of surfactant proteins (Fan et al., 2000
). Immunostaining analyses revealed a striking reduction in expression of two surfactant proteins, SFTPC and SFTPA in lungs of Ndst1-knockout mice. At 16.5 d.p.c., staining of SFTPC was specifically detected in the distal epithelium (Fig. 2C), whereas staining of SFTPA was detected throughout the epithelium, including proximal and distal parts, in lungs of wild-type mice (Fig. 2A). Significantly, both proteins were barely detectable in mutant lungs (Fig. 2B,D). Furthermore, analysis of the mutant lungs at 18.5 d.p.c. revealed a notable decrease of SFTPC-positive cells (Fig. 2E-G). In parallel, real-time RT-PCR assay indicated that mRNA levels of Sftpc, Sftpa and Sftpb were significantly reduced in mutant lung at 17.5 d.p.c. (Fig. 2Y). These observations imply that inactivation of Ndst1 leads to defective development of distal epithelium and immaturity of type II alveolar cells, which fail to produce surfactant proteins.
|
The expression pattern of the proximal bronchiole epithelium marker CC10 (UTER/Clara Cell 10 protein), did not alter between Ndst1 mutant and control lungs (Fig. 2M,N). Immunofluorescent examination revealed that the number of CC10-immunoreactive cells did not change in mutant lungs (Fig. 2O-Q). However, the bronchioles lining with these cells were less dilated in mutant lungs than in normal littermates (Fig. 2O,P), suggesting that development of proximal bronchiole epithelium was affected by Ndst1 inactivation.
There is a close relationship between blood vessel and lung structural development. Immunofluorescent examination showed that the mutant lungs had no significant alteration in distributions of caveolin-1 (CAV1) and
-smooth muscle actin (SMA), which are molecular markers of blood vessels (Fig. 2R-V for caveolin-1; Fig. 2W,X for SMA). It appears that inactivation of Ndst1 does not affect the lung blood vessel development.
BMP signaling pathway is upregulated in Ndst1–/– lungs
The embryonic lung in Grem1–/– mice exhibits an abnormal `proximalized' phenotype, which is caused by BMP-signaling dysregulation (Michos et al., 2004
). Thus, BMP signaling was examined in Ndst1–/– lungs. Binding of BMPs to preformed heteromeric receptor complexes results in the phosphorylation of Smad proteins, and subsequent stimulation of expression of Id1 (Hollnagel et al., 1999
; Nohe et al., 2002
), Dlx5 (Holleville et al., 2003
; Miyama et al., 1999
) and Tbx1 (Bachiller et al., 2003
). Phosphorylated Smad1 (Smad1-P) was highly upregulated in lungs of 16.5 d.p.c. mutant mice (Fig. 3A,B), and upregulation of ID1 protein was evident at 18.5 d.p.c. (Fig. 3E,F). Interestingly, overexpressed ID1 in mutant lungs seemed to localize not only in the nucleus, but also in the cytoplasm. A similar phenomenon was observed in small cell lung cancer with upregulated ID1, although the reason for this was not clear (Kamalian et al., 2008
). mRNA levels of both Dlx5 and Tbx1 were also increased in lungs of Ndst1-deficient animals (Fig. 3I). All these data demonstrate that the BMP-signaling pathway is upregulated in Ndst1–/– lungs. However, mRNA levels of Bmp2, Bmp4, Bmp5 and Bmp7 were not changed in Ndst1 mutant lungs (Fig. 3J), indicating that the upregulation of BMP signaling in the mutants was not caused by an increased BMPs.
|
Blockade of BMP signaling rescues the defective differentiation of type I and type II cells in Ndst1-null mice
To determine whether dysregulated BMP signaling caused the defective differentiation of type I and type II cells in Ndst1-null lungs, Noggin, a BMP antagonist, was applied to block BMP signaling. Similarly to wild-type lung explants (Fig. 4A-H), treatment of 15.5 d.p.c. Ndst1–/– lungs with noggin resulted in significantly downregulated expression of Smad1-P protein (Fig. 4K,L), and upregulation of SFTPC (Fig. 4M,N) and AQP5 (Fig. 4O,P). Furthermore, BrdU labeling indicated that cell proliferation was decreased in the presence of noggin (Fig. 4I,J). These results demonstrate that block of BMP signaling could rescue the developmental failure in type I and type II cells, or their precursor cells, in mutant lungs. And it reinforced the idea that upregulation of BMP signaling contributes to the defective lung development in Ndst1 mutants. However, exogenous noggin inhibited the proliferation of both wild-type and mutant lungs (Fig. 4R), indicating that a physiological concentration of BMP is essential for cellular processes, including DNA synthesis and mitosis.
|
|
|
It was unexpected that exogenous heparin could largely rescue BMP2 binding to the cell surface and consequent internalization in Ndst1–/– mice (Fig. 6J,L,U), whereas its effect on wild-type cells was much less significant (Fig. 6I,K,U). It seems that not only cell surface HS, but also extracellular HS, participates in the internalization of BMP.
Exogenous heparin could also rescue the phenotype of Ndst1–/– lung
Since exogenous heparin could rescue the BMP binding and internalization, it might be also able to rescue the dysregulated BMP signalling and consequent morphogenetic defects in Ndst1–/– lungs. Treatment of 15.5 d.p.c. wild-type and Ndst1–/– lung explants with 10 µg/ml exogenous heparin, which has a higher content of N-sulfation than HS, reduced the expression of Smad1-P (Fig. 7A,B,G,H) and enhanced the expression of SFTPC and AQP5 (Fig. 7C-F,I-L). The findings confirm that impaired BMP signaling with N-sulfation or heparin can facilitate the differentiation of type I and type II alveolar cells.
|
Western blot assays were also performed. Similarly to results of the histochemical assays, Ndst1–/– lung explants displayed a much higher level of phosphorylation of Smad1 than wild-type lung explants, whereas treatment with noggin or heparin dramatically reduced this abnormal high level (Fig. 7Q). This confirmed the inhibitory function of heparin in BMP signaling.
| Discussion |
|---|
|
|
|---|
NDST1-dependent modification is essential for HS modulation of the BMP-signaling pathway and BMP internalization
Here, we propose that dysregulation of BMP signaling pathway contributes to the defective morphogenesis in Ndst1-null lung. Consistently, similar abnormal septation of the lung airway epithelium was observed in embryonic lung when GREM1, an antagonist of BMP, was deficient (Michos et al., 2004
). By contrast, overexpression of BMP4 in embryonic distal lung epithelium results in thicker mesenchyma than observed in control and in the `emphysematous' phenotype (Bellusci et al., 1996
). Nog–/– mice exhibit abnormal morphology with a malformed and truncated lobe (Weaver et al., 2003
). There are several possible explanations for these discrepancies. First, endogenous GREM1 is expressed in proximal airway epithelium (Weaver et al., 1999
), whereas noggin is normally expressed in the distal mesenchyme (Lu et al., 2001
). By inhibition of BMP signaling, GREM1 and noggin might have different roles in spatial and temporal regulation of lung development. Thus, the phenotypes observed in these mice models result from deficiencies in partial epithelium or mesenchyme differentiation alone. Similarly, ectopic expression of BMP4 in distal epithelium had no obvious affect on the epithelium in the proximal airway (Bellusci et al., 1996
). HS plays an upstream regulatory role in the BMP-signaling pathway, and thereby modulates the differentiation of all the epithelium and mesenchyme. To determine how HS does this, further conditional gene knockout studies are needed. In addition, depending on concentration, BMP promotes mesenchyme proliferation or death (Bellusci et al., 1996
). In Bmp4 transgenic mice, a high level of BMP4 resulted in cell death and inhibition of cell proliferation. However, in our model and in GREM1-deficient mice, cell proliferation increased, probably because of the occurrence of endogenous BMP at proper concentrations. Finally, HS modulates not only BMP signaling, but also other important pathways during lung development, including the FGF-signaling pathway (supplementary material Fig. S1). Thus, the phenotype we report here might result from dysregulation of several signaling pathways.
Accordingly, we asked how NDST1-dependent HS was involved in the BMP-signaling pathway. It is reported that HS binds to the N-terminal of BMP-2 and modulates the function of BMP2 in chick limb bud assays (Ruppert et al., 1996
). In C2C12 myoblast cells, blockade of cell surface HSPG sulfation or removal of the GAG chain enhanced BMP2 signaling and bioactivity, which could be attenuated by exogenous heparin (Jiao et al., 2007
). In this study, we further proved that the binding of HS to BMP inhibits BMP signalling, rather than facilitates it, in lung development. In particular, NDST1-dependent modification is essential for the activity of HS in the regulation of BMP-signaling pathways. In addition to regulating BMP binding, HS also has a role in binding noggin to the cell surface. Therefore, reduced noggin binding in Ndst1 mutant lungs might also contribute to the hyperactivity of the BMP-signaling pathway (Viviano et al., 2004
).
Recent studies have implied that cell surface HSPGs are also involved in cellular internalization of proteins (Belting, 2003
; Jiao et al., 2007
; Payne et al., 2007
). Live-cell imaging indicates that HSPGs mediate cationic ligand internalization via a clathrin- and caveolin-independent, but flotillin- and dynamin-dependent pathway (Payne et al., 2007
). Our data further demonstrate that the NDST1-dependent HS modifications, including N-deacetylation and N-sulfation, are required for BMP internalization. We also observed that HS-mediated BMP internalization might be independent of BMP receptors (Fig. 6C,G). More interestingly, we found that exogenous heparin could partly rescue the BMP internalization defects caused by loss of NDST1 (Fig. 6J,L). This implies that, not only cell-surface HS, but also extracellular heparin or HS, also contribute to BMP internalization, which has not been reported before.
Taken together, it is postulated that BMPs that bind to HS prefer to internalise, whereas BMPs that bind to receptors prefer to activate downstream signaling. The balance between BMP binding to HS and to receptors might control BMP signaling.
Compared with our previous work on Ndst1 mutant bone (Hu et al., 2007
), the activity of HS in modulating signaling pathways seems variable in different tissues. First, unlike in embryonic lung, exogenous heparin might not be able to rescue the morphogenetic defects in Ndst1–/– embryonic limb bone. Second, FGF1 binding to the cell surface is attenuated in mutant lung but not in mutant bone. It is conceivable that other factors participate in the process of HS binding to cytokines.
In summary, previous studies on the Ndst1-knockout mouse indicate that HS could regulate various secreted ligands in different tissue contexts. Therefore, the tissue-specific regulation of HS and secreted ligands might contribute to the observation that HS plays a vital role in different developmental tissues via various signaling pathways. In this study, we provide a mouse model for exploring the function of HS in BMP signaling. We point out the different roles of HS in regulating BMP signaling and BMP internalization, and thus present an explanation for the mechanistic involvement of NDST1-dependent HS in modulation of the BMP-signaling pathway during lung development,
In addition to insights into developmental regulation, our study also has important clinical implications. We found an inhibitory effect of heparin on the modulation of BMP signalling, which might provide an explanation for the clinical observations that heparin can improve outcome in small-cell lung cancer (SCLC) (Altinbas et al., 2004
; Lebeau et al., 1994
), in which BMP8 is overexpressed (Henderson et al., 2005
).
| Materials and Methods |
|---|
|
|
|---|
Histological and immunohistochemical analysis
Embryonic lungs were fixed overnight in 4% buffered formaldehyde at 4°C and embedded in paraffin for sectioning. For histological analysis, 5 µm sections were stained with hematoxylin and eosin, mounted in xylene-based medium and photographed. For immunohistochemistry, 5 µm tissue sections were pretreated with 10 mM sodium citrate buffer (pH 6.0) at 95°C, and then incubated overnight at 4°C with anti-CC10 (T-18), anti-SFTPA (N-19), anti-SFTPC (M-20), anti-AQP5 (G-19), anti-caveolin-1 (N-20), anti-Smad1-P (Ser463-Ser465), anti-Id1 (C-20), anti-Patched (G-19), anti-Gli1 (N-16) (all from Santa Cruz Biotechnology, Santa Cruz, CA), anti-SMA (Sigma, St Louis, MO) or anti-HepSS-1 (Seikagaku Corp., Tokyo, Japan). For enzymatic staining, biotinylated secondary antibodies and the ABC staining system (Santa Cruz) were applied. The images were captured on a cooled CCD camera (SPOT II, Diagnostic Instruments, Sterling Heights, MI) on an Olympus BX51 microscope. For immunofluorescence, secondary antibodies conjugated with appropriate fluorochrome, FITC, Cy3, Cy5 (Jackson ImmunoResearch, West Grove, PA), were used. Digital images were analyses by confocal laser-scanning microscope (Leica SP2 system) and processed using Adobe Photoshop. At least three embryos for each genotype were analyzed for each antibody.
RT-PCR
Total RNA was isolated from lungs of 17.5 d.p.c. Ndst1–/– and wild-type embryos using Trizol Reagent (Invitrogen, Paisley, UK), and then reverse transcribed with Super-scriptase (Invitrogen). The primers used in PCR assays were Ndst1 (forward, 5'-CTG CCC TGG CGT GCC TCC-3'; reverse, 5'-TGG GCC GTG TCA CAT AGA GCA GT-3'); Ndst3 (forward, 5'-TCA CAT GCA GCC CCA CCT CTT-3'; reverse, 5'-GCT CCC CTC CAT GAA TAC TCT TGT-3'); Ndst2, Ndst4 (Pan et al., 2006
); Bmp2 (forward, 5'-TCT TCC GGG AAC AGA TAC AGG-3'; reverse, 5'-TCT CCT CTA AAT GGG CCA CTT-3'); Bmp4 (Zhang et al., 2007
), β-actin (Actb) (forward, 5'-CTG GCT GGC CGG GAC CTG ACA-3'; reverse, 5'-ACC GCT CGT TGC CAA TAG TGA TGA-3'). Actb was used as an internal control for quantification.
Real-time PCR assays were performed on a DNA Engine Opticon 2 (MJ Research, Watertown, MA) using the DyNAmo SYBR Green qPCR kit (FinnzymesOy, Espoo, Finland). The data were expressed as relative mRNA (gene) copies, which were normalized to the expression level of Actb. The following primers were used: Aqp5 (forward, 5'-AGC CTT ATC CAT TGG CTT GTC-3'; reverse, 5'-TGA GAG GGG CTG AAC CGA T-3'); SftpA (Okubo and Hogan, 2004
); SftpB (forward, 5'-ACG TCC TCT GGA AGC CTT CA-3'; reverse, 5'-TGT CTT CTT GGA GCC ACA ACA G-3'); SftpC (forward, 5'-ACC CTG TGT GGA GAG CTA CCA-3'; reverse, 5'-TTT GCG GAG GGT CTT TCC T-3'); Dlx5 (forward, 5'-GTC CCA AGC ATC CGA TCC G-3'; reverse, 5'-GCT TTG CCA TAA GAA GCA GAG G-3'); Tbx1 (forward, 5'-AGG CAG ACG AAT GTT CCC C-3'; reverse, 5'-GCT TGT CAT CTA CGG GCA CA-3').
BrdU labeling and detection
Mouse embryos were labeled with BrdU (BrdU labeling and detection kit II, Roche, Germany) by intraperitoneal injection of 10 mM BrdU (1-2 ml per 100 g body weight) into pregnant females 1 hour before sacrifice. Cultured lung explants were treated with 100 µM BrdU for 1.5 hours before harvesting, and then were fixed in 95% ethanol at 4°C and embedded in paraffin. Antibody staining of embryo sections was carried out according to the manufacturer's instructions. The number of BrdU-positive nuclei and total cells in each field of vision was estimated from eight sections from three animals for each genotype.
In situ HS-binding assays
The assays were performed on paraffin-embedded sections essentially as previously described for cryosections (Chang et al., 2000
; Friedl et al., 1997
). Briefly, after blocking, sections were incubated with 15 nM BMP2, 15 nM BMP4 and 30 nM FGF1 (all from R&D Systems, Wiesbaden, Germany), respectively. Then, sections were incubated with anti-BMP2, anti-BMP4, anti-FGF1 antibodies (all from R&D Systems) and stained using the ABC staining system (Santa Cruz).
Organ culture of embryonic lung explants
Mouse embryonic lungs were cultured essentially as previously described (Dean et al., 2005
; del Moral et al., 2006
). Briefly, lungs were isolated from 15.5 d.p.c. crosses of Ndst1+/– mice. They were placed in a six-well plate on an 8 µm Nucleopore membrane floating in 1 ml BGJ-B medium (GibcoBRL, Grand Island, NY) with antibiotic/antimycotic (Life Technologies, Paisley, UK) and 0.1% BSA, and were maintained at 37°C in a humidified 5% CO2 incubator. Lung explants were cultured in medium supplemented with 10 µg/ml heparin (Sigma) or with 500 ng/ml noggin (R&D Systems) for 3 days and were compared with explants cultured in BGJ-B medium. The medium was changed every day.
Primary lung epithelial and mesenchymal cell cultures
Epithelial and mesenchymal cell cultures were obtained by differential adhesion as previously described (Lebeche et al., 1999
). Briefly, whole lungs were dissected at 15.5 d.p.c. and digested with 0.4% dispase 0.8% Collagenase (37°C, 60 minutes; GibcoBRL) to give rise to single cells. The resulting filtered suspension was plated in 30 mm dishes and incubated at 37°C in a humidified 5% CO2 incubator for 1 hour for differential adhesion. The supernatant containing epithelium cells was removed and centrifuged at 1000 r.p.m. for 10 minutes at room temperature. The cell pellet was resuspended in Dulbecco's modified Eagle's medium (DMEM) with 10% heat-inactivated fetal bovine serum, and plated in dishes. The mesenchymal cells attached to the dish were washed with PBS and cultured with fresh medium.
BMP internalization assays
BMP2 internalization was performed mostly as previously described (Jiao et al., 2007
). Briefly, BMP2 (12 µl of 400 ng/ml; R&D systems) was incubated with goat anti-BMP2 antibody (40 µl of 500 ng/ml; Santa Cruz) for 30 minutes at 37°C to form the BMP2-anti-BMP2 complex. Lung epithelial or mesenchymal cells, seeded on glass coverslips in 24-well plates, were incubated with BMP2-anti-BMP2 complex at 4°C for 30 minutes. After a wash with ice-cold serum-free DMEM, the cells were incubated at 37°C for 30 minutes. Cells were then incubated with FITC-conjugated secondary antibody (Jackson ImmunoResearch) and 4,6-diamidino-2-phenylindole (DAPI) and examined by confocal laser-scanning microscope (Leica SP2 system) after being fixed.
Western blot
Lung explants were homogenized and lysed after treated with noggin and heparin. Then lysates were collected after brief concentration. Immunoblotting was performed as described previously (Huang et al., 2002
) with primary antibodies against Smad1-P (Cell Signaling Technology), Smad1 (a kind gift from Yeguang Chen, Tsinghua University, Beijing, China) and β-actin (Sigma).
Statistical analysis
The Student's t-test was used to determine levels of difference between groups, and P values for significance were set to 0.05. Values for all measurements were expressed as the means ± s.d.
| Footnotes |
|---|
* These authors contributed equally to this work ![]()
We are grateful to Xinhua Lin and Xiaoyan Ding for helpful discussions and Yeguang Chen for supplying antibody against Smad1. This work was supported by Minster for Science and Technology Grant G1998051007 and Chinese High-Tech R&D Program (863)-2001AA231011 and 0022Z2002.
| References |
|---|
|
|
|---|
Abramsson, A., Kurup, S., Busse, M., Yamada, S., Lindblom, P., Schallmeiner, E., Stenzel, D., Sauvaget, D., Ledin, J., Ringvall, M. et al. (2007). Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev. 21, 316-331.
Aikawa, J. and Esko, J. D. (1999). Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family. J. Biol. Chem. 274, 2690-2695.
Aikawa, J., Grobe, K., Tsujimoto, M. and Esko, J. D. (2001). Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase: structure and activity of the fourth member, NDST4. J. Biol. Chem. 276, 5876-5882.
Altinbas, M., Coskun, H. S., Er, O., Ozkan, M., Eser, B., Unal, A., Cetin, M. and Soyuer, S. (2004). A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J. Thromb. Haemost. 2, 1266-1271.[CrossRef][Medline]
Bachiller, D., Klingensmith, J., Shneyder, N., Tran, U., Anderson, R., Rossant, J. and De Robertis, E. M. (2003). The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 130, 3567-3578.
Bellusci, S., Henderson, R., Winnier, G., Oikawa, T. and Hogan, B. L. (1996). Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 122, 1693-1702.[Abstract]
Bellusci, S., Furuta, Y., Rush, M. G., Henderson, R., Winnier, G. and Hogan, B. L. (1997). Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 124, 53-63.[Abstract]
Belting, M. (2003). Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28, 145-151.[CrossRef][Medline]
Chang, Z., Meyer, K., Rapraeger, A. C. and Friedl, A. (2000). Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J. 14, 137-144.
Dean, C. H., Miller, L. A., Smith, A. N., Dufort, D., Lang, R. A. and Niswander, L. A. (2005). Canonical Wnt signaling negatively regulates branching morphogenesis of the lung and lacrimal gland. Dev. Biol. 286, 270-286.[CrossRef][Medline]
del Moral, P. M., De Langhe, S. P., Sala, F. G., Veltmaat, J. M., Tefft, D., Wang, K., Warburton, D. and Bellusci, S. (2006). Differential role of FGF9 on epithelium and mesenchyme in mouse embryonic lung. Dev. Biol. 293, 77-89.[CrossRef][Medline]
Eblaghie, M. C., Reedy, M., Oliver, T., Mishina, Y. and Hogan, B. L. (2006). Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells. Dev. Biol. 291, 67-82.[CrossRef][Medline]
Eriksson, I., Sandback, D., Ek, B., Lindahl, U. and Kjellen, L. (1994). cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. J. Biol. Chem. 269, 10438-10443.
Esko, J. D. and Selleck, S. B. (2002). Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471.[CrossRef][Medline]
Fan, G., Xiao, L., Cheng, L., Wang, X., Sun, B. and Hu, G. (2000). Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett. 467, 7-11.[CrossRef][Medline]
Fisher, M. C., Li, Y., Seghatoleslami, M. R., Dealy, C. N., Kosher, R. A. (2006). Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol. 25, 27-39.[CrossRef][Medline]
Ford-Perriss, M., Guimond, S. E., Greferath, U., Kita, M., Grobe, K., Habuchi, H., Kimata, K., Esko, J. D., Murphy, M. and Turnbull, J. E. (2002). Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling. Glycobiology 12, 721-727.
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., Eriksson, I., Ledin, J., Hellman, L. and Kjellen, L. (1999). Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400, 773-776.[CrossRef][Medline]
Friedl, A., Chang, Z., Tierney, A. and Rapraeger, A. C. (1997). Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am. J. Pathol. 150, 1443-1455.[Abstract]
Grobe, K., Ledin, J., Ringvall, M., Holmborn, K., Forsberg, E., Esko, J. D. and Kjellen, L. (2002). Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim. Biophys. Acta 1573, 209-215.[Medline]
Grobe, K., Inatani, M., Pallerla, S. R., Castagnola, J., Yamaguchi, Y. and Esko, J. D. (2005). Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 132, 3777-3786.
Hacker, U., Nybakken, K. and Perrimon, N. (2005). Heparan sulphate proteoglycans: the sweet side of development. Nat. Rev. Mol. Cell. Biol. 6, 530-541.[CrossRef][Medline]
Hashimoto, Y., Orellana, A., Gil, G. and Hirschberg, C. B. (1992). Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J. Biol. Chem. 267, 15744-15750.
Henderson, L. J., Coe, B. P., Lee, E. H., Girard, L., Gazdar, A. F., Minna, J. D., Lam, S., MacAulay, C. and Lam, W. L. (2005). Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells. Br. J. Cancer 92, 1553-1560.[CrossRef][Medline]
Holleville, N., Quilhac, A., Bontoux, M. and Monsoro-Burq, A. H. (2003). BMP signals regulate Dlx5 during early avian skull development. Dev. Biol. 257, 177-189.[CrossRef][Medline]
Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U. and Nordheim, A. (1999). Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838-19845.
Hu, Z., Yu, M. and Hu, G. (2007). NDST-1 modulates BMPR and PTHrP signaling during endochondral bone formation in a gene knockout model. Bone 40, 1462-1474.[CrossRef][Medline]
Huang, R., Wu, T., Xu, L., Liu, A., Ji, Y. and Hu, G. (2002). Upstream binding factor up-regulated in hepatocellular carcinoma is related to the survival and cisplatin-sensitivity of cancer cells. FASEB J. 16, 293-301.
Humphries, D. E., Wong, G. W., Friend, D. S., Gurish, M. F., Qiu, W. T., Huang, C., Sharpe, A. H. and Stevens, R. L. (1999). Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400, 769-772.[CrossRef][Medline]
Jiao, X., Billings, P. C., O'Connell, M. P., Kaplan, F. S., Shore, E. M. and Glaser, D. L. (2007). Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J. Biol. Chem. 282, 1080-1086.
Kamalian, L., Gosney, J. R., Forootan, S. S., Foster, C. S., Bao, Z. Z., Beesley, C. and Ke, Y. (2008). Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin. Cancer Res. 14, 2318-2325.
Krane, C. M., Towne, J. E. and Menon, A. G. (1999). Cloning and characterization of murine Aqp5: evidence for a conserved aquaporin gene cluster. Mamm. Genome 10, 498-505.[CrossRef][Medline]
Kreda, S. M., Gynn, M. C., Fenstermacher, D. A., Boucher, R. C. and Gabriel, S. E. (2001). Expression and localization of epithelial aquaporins in the adult human lung. Am. J. Respir. Cell Mol. Biol. 24, 224-234.
Kusche-Gullberg, M., Eriksson, I., Pikas, D. S. and Kjellen, L. (1998). Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes. J. Biol. Chem. 273, 11902-11907.
Lebeau, B., Chastang, C., Brechot, J. M., Capron, F., Dautzenberg, B., Delaisements, C., Mornet, M., Brun, J., Hurdebourcq, J. P. and Lemarie, E. (1994). Subcutaneous heparin treatment increases survival in small cell lung cancer: "Petites Cellules" Group. Cancer 74, 38-45.[CrossRef][Medline]
Lebeche, D., Malpel, S. and Cardoso, W. V. (1999). Fibroblast growth factor interactions in the developing lung. Mech. Dev. 86, 125-136.[CrossRef][Medline]
Lin, X. (2004). Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131, 6009-6021.
Lindahl, U., Kusche-Gullberg, M. and Kjellen, L. (1998). Regulated diversity of heparan sulfate. J. Biol. Chem. 273, 24979-24982.
Lu, M. M., Yang, H., Zhang, L., Shu, W., Blair, D. G. and Morrisey, E. E. (2001). The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev. Dyn. 222, 667-680.[CrossRef][Medline]
Michos, O., Panman, L., Vintersten, K., Beier, K., Zeller, R. and Zuniga, A. (2004). Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131, 3401-3410.
Miettinen, P. J., Warburton, D., Bu, D., Zhao, J. S., Berger, J. E., Minoo, P., Koivisto, T., Allen, L., Dobbs, L., Werb, Z. et al. (1997). Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev. Biol. 186, 224-236.[CrossRef][Medline]
Miyama, K., Yamada, G., Yamamoto, T. S., Takagi, C., Miyado, K., Sakai, M., Ueno, N. and Shibuya, H. (1999). A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev. Biol. 208, 123-133.[CrossRef][Medline]
Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I. and Knaus, P. (2002). The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277, 5330-5338.
Okubo, T. and Hogan, B. L. (2004). Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J. Biol. 3, 11.[CrossRef][Medline]
Pan, Y., Woodbury, A., Esko, J. D., Grobe, K. and Zhang, X. (2006). Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development 133, 4933-4944.
Pan, Y., Carbe, C., Powers, A., Zhang, E. E., Esko, J. D., Grobe, K., Feng, G. S. and Zhang, X. (2008). Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 135, 301-310.
Payne, C. K., Jones, S. A., Chen, C. and Zhuang, X. (2007). Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic 8, 389-401.[CrossRef][Medline]
Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson, A. M., Kjellen, L. and Forsberg, E. (2000). Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J. Biol. Chem. 275, 25926-25930.
Ruppert, R., Hoffmann, E. and Sebald, W. (1996). Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237, 295-302.[Medline]
Salmivirta, M., Lidholt, K. and Lindahl, U. (1996). Heparan sulfate: a piece of information. FASEB J. 10, 1270-1279.[Abstract]
Smith, W. C. and Harland, R. M. (1992). Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70, 829-840.[CrossRef][Medline]
Viviano, B. L., Paine-Saunders, S., Gasiunas, N., Gallagher, J. and Saunders, S. (2004). Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J. Biol. Chem. 279, 5604-5611.
Warburton, D., Schwarz, M., Tefft, D., Flores-Delgado, G., Anderson, K. D. and Cardoso, W. V. (2000). The molecular basis of lung morphogenesis. Mech Dev 92, 55-81.[CrossRef][Medline]
Weaver, M., Yingling, J. M., Dunn, N. R., Bellusci, S. and Hogan, B. L. (1999). Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development. Development 126, 4005-4015.[Abstract]
Weaver, M., Batts, L. and Hogan, B. L. (2003). Tissue interactions pattern the mesenchyme of the embryonic mouse lung. Dev. Biol. 258, 169-184.[CrossRef][Medline]
Weinstein, M., Xu, X., Ohyama, K. and Deng, C. X. (1998). FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125, 3615-3623.[Abstract]
Yabe, T., Hata, T., He, J. and Maeda, N. (2005). Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. Glycobiology 15, 982-993.
Zhang, Y., Rath, N., Hannenhalli, S., Wang, Z., Cappola, T., Kimura, S., Atochina-Vasserman, E., Lu, M. M., Beers, M. F. and Morrisey, E. E. (2007). GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo. Development 134, 189-198.
Zimmerman, L. B., De Jesus-Escobar, J. M. and Harland, R. M. (1996). The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599-606.[CrossRef][Medline]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
R. I. Zuberi, X. N. Ge, S. Jiang, N. S. Bahaie, B. N. Kang, R. M. Hosseinkhani, E. M. Frenzel, M. M. Fuster, J. D. Esko, S. P. Rao, et al. Deficiency of Endothelial Heparan Sulfates Attenuates Allergic Airway Inflammation J. Immunol., September 15, 2009; 183(6): 3971 - 3979. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hu, C. Wang, Y. Xiao, N. Sheng, Y. Chen, Y. Xu, L. Zhang, W. Mo, N. Jing, and G. Hu NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development Development, May 1, 2009; 136(9): e1 - e1. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||